These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29796029)

  • 21. Intravenous streptokinase in acute myocardial infarction (I.S.A.M.): assessment of left ventricular function 1 and 7 months after infarction by radionuclide ventriculography.
    Voth E; Tebbe U; Schicha H; Neumann P; Schröder R; Neuhaus KL; Emrich D
    Eur Heart J; 1990 Oct; 11(10):885-96. PubMed ID: 2265640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TERIMA-2: national extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba.
    TERIMA Group of Investigators
    Thromb Haemost; 2000 Dec; 84(6):949-54. PubMed ID: 11330244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction].
    Raffo C; Bartolucci J; Corbalán R; Aninat M; Torres H; Prieto JC; Lanas F; Chávez E; Cumsille F; Nazzal C;
    Rev Med Chil; 2006 Oct; 134(10):1249-57. PubMed ID: 17186094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Adverse Drug Reactions in CAD STEMI Patients Treated in the Cardiac Intensive Care Unit at the Public Hospital in Bandung, Indonesia.
    Amalia L; Anggadireja K; Aprami TM; Septiani V
    Sci Pharm; 2016; 84(1):167-79. PubMed ID: 27110507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-infectives-induced adverse drug reactions in hospitalized patients.
    Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events to Houttuynia injection: A systematic review.
    Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
    J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort.
    Ederhy S; Cohen A; Boccara F; Puymirat E; Aissaoui N; Elbaz M; Bonnefoy-Cudraz E; Druelles P; Andrieu S; Angoulvant D; Furber A; Ferrières J; Schiele F; Cottin Y; Simon T; Danchin N;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):657-669. PubMed ID: 31761740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of primary percutaneous coronary intervention and streptokinase for acute isolated inferior ST elevation myocardial infarction with a predicted low risk profile.
    Norgaz T; Gorgulu S; Aksu H; Hobikoglu G; Ergelen M; Onturk E; Simsek D; Narin A
    Med Sci Monit; 2010 Sep; 16(9):CR416-22. PubMed ID: 20802413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients.
    Grijseels EW; Bouten MJ; Lenderink T; Deckers JW; Hoes AW; Hartman JA; van der Does E; Simoons ML
    Eur Heart J; 1995 Dec; 16(12):1833-8. PubMed ID: 8682015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reaction monitoring during antimicrobial therapy for septicemia patients at a university hospital in New Delhi.
    Alam MS; Pillai KK; Abdi SAH; Kapur P; Pillai PK; Nagarajan K
    Korean J Intern Med; 2018 Nov; 33(6):1203-1209. PubMed ID: 28874042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions in hospitalized cardiac patients: characteristics and risk factors.
    Mugosa S; Bukumirić Z; Kovacević A; Bosković A; Protić D; Todorović Z
    Vojnosanit Pregl; 2015 Nov; 72(11):975-81. PubMed ID: 26731971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Adverse Drug Reaction in the Medical Wards of a Teaching Hospital: A Prospective Observational Cohort Study.
    Peter JV; Varghese GH; Alexander H; Tom NR; Swethalekshmi V; Truman C; Kumar TR; Sivakumar T
    Curr Drug Saf; 2016; 11(2):164-71. PubMed ID: 26916785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pattern of Adverse Drug Reactions in Children Attending the Department of Pediatrics in a Tertiary Care Center: A Prospective Observational Study.
    Digra KK; Pandita A; Saini GS; Bharti R
    Clin Med Insights Pediatr; 2015; 9():73-8. PubMed ID: 26309424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational study comparing pharmacoinvasive strategy with primary percutaneous coronary intervention in patients presenting with ST elevation myocardial infarction to a tertiary care centre in India.
    Alex AG; Lahiri A; ; Geevar T; George OK
    J Postgrad Med; 2018; 64(2):80-85. PubMed ID: 29067927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.
    O'Neill WW; Weintraub R; Grines CL; Meany TB; Brodie BR; Friedman HZ; Ramos RG; Gangadharan V; Levin RN; Choksi N
    Circulation; 1992 Dec; 86(6):1710-7. PubMed ID: 1451242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.